Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy for esophageal cancer: Where are we now and where can we go
Yoshiaki Shoji, Kazuo Koyanagi, Kohei Kanamori, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 19, pp. 2496-2501
Open Access | Times Cited: 13

Showing 13 citing articles:

The efficacy and safety of PD-1 inhibitors combined with chemotherapy treatment for advanced esophageal cancer: a network meta-analysis
Jinhui Tian, Li Zhang, Fan Lin, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Juniperus indica Bertol Extract Combined with 5-Fluorouracil Synergistically Suppresses the Growth of Esophageal Squamous Cell Carcinoma Cells
Hong-Wei Gao, Kai‐Fu Chang, Xiao-Fan Huang, et al.
Natural Product Communications (2025) Vol. 20, Iss. 2
Open Access
Immunotherapy in the Management of Penile Cancer—A Systematic Review
Hossein Taghizadeh, Harun Fajković
Cancers (2025) Vol. 17, Iss. 5, pp. 883-883
Open Access
101 Machine Learning Algorithms for Mining Esophageal Squamous Cell Carcinoma Neoantigen Prognostic Models in Single-Cell Data
Yingjie Sun, Yuheng Tang, Qi Qi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3373-3373
Open Access
Palliative external beam radiotherapy for dysphagia management in advanced esophageal cancer: a narrative perspective
Atsuto Katano
ONCOLOGIE (2025)
Closed Access
Immunotherapy-associated autoimmune hemolytic anemia induced by anti-PD-1 therapy in esophageal cancer: A case report and literature review
Zijian Qiu, Mai Sun, Chunyan Dai, et al.
Medicine (2025) Vol. 104, Iss. 15, pp. e42174-e42174
Open Access
Advancements and challenges in the treatment of esophageal cancer: A comprehensive review
Grigorios Christodoulidis, Sara Eirini Agko, Konstantinos Eleftherios Koumarelas, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 12, pp. 1463-1467
Closed Access | Times Cited: 1
Postoperative adjuvant immunotherapy for pathological stage II–IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates
Xihao Xie, Hai Zhang, Haiquan He, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
Sung Eun Kim, Kyoungwon Jung, Moo In Park
Journal of Digestive Cancer Research (2024) Vol. 12, Iss. 2, pp. 72-81
Open Access
Editor-in-Chief articles of choice and comments from January to June 2024
Andrzej S. Tarnawski
World Journal of Gastroenterology (2024) Vol. 30, Iss. 34, pp. 3875-3882
Closed Access
Conversion surgery for esophageal and esophagogastric junction cancer
Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 12, pp. 1777-1784
Open Access
BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation
Qin Wang, Qingrong Li, Lei Xu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 17, Iss. 1
Closed Access
Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma
Shilong Wu, Chenyang Xu, Huafeng Liu
Frontiers in Medicine (2024) Vol. 11
Open Access
Page 1

Scroll to top